Literature DB >> 3259982

The hazards of using active clinic patients as a source of subjects for clinical studies.

A S Detsky1, K O'Rourke, P N Corey, N Johnston, S Fenton, K N Jeejeebhoy.   

Abstract

The authors describe and empirically demonstrate a form of bias that results from deriving subjects for clinical studies from available patients currently being followed in specific disease clinics instead of inception cohorts (patients enrolled at a uniform and early point in their disease). They label this effect "clinic patient bias." It is a variation of prevalence-incidence (Neyman) bias in that it also results from the time gap between the onset of a specific characteristic (a risk factor, exposure or disease) and enrollment in the study, causing selective exclusion of fatal or short episodes, or mild or silent cases. Clinic patient bias may distort an estimate of relative risk in either direction. The empirical example is derived from a study of risk factors for developing complications such as peritonitis among end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis (CAPD). The use of available clinic patients rather than an inception cohort (patients newly beginning CAPD) resulted in the demonstration of false apparent risk relationships for two variables: the calendar date when patients began CAPD (with those enrolled at an earlier time appearing to be at lower risk), and serum albumin level at the start of CAPD (with those having lower albumin levels appearing to be at higher risk). This example demonstrates one of the potential hazards of using active or available clinic patients as a source of subjects for clinical studies.

Entities:  

Mesh:

Year:  1988        PMID: 3259982     DOI: 10.1007/bf02596342

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  8 in total

1.  Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.

Authors:  M MERRELL; L E SHULMAN
Journal:  J Chronic Dis       Date:  1955-01

2.  Statistics; servant of all sciences.

Authors:  J NEYMAN
Journal:  Science       Date:  1955-09-02       Impact factor: 47.728

3.  When research results are in conflict.

Authors:  J C Bailar
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

4.  Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.

Authors:  P W Wilson; R J Garrison; W P Castelli
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

5.  Bias in analytic research.

Authors:  D L Sackett
Journal:  J Chronic Dis       Date:  1979

6.  An empirical demonstration of Berkson's bias.

Authors:  R S Roberts; W O Spitzer; T Delmore; D L Sackett
Journal:  J Chronic Dis       Date:  1978-02

7.  Comparison of prevalence, case history and incidence data in assessing the potency of risk factors in coronary heart disease.

Authors:  G D Friedman; W B Kannel; T R Dawber; P M McNamara
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

8.  A prospective study of postmenopausal estrogen therapy and coronary heart disease.

Authors:  M J Stampfer; W C Willett; G A Colditz; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

  8 in total
  4 in total

Review 1.  The selection of data sources for use in modelling studies.

Authors:  M J Nuijten
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

Review 2.  The clinical prognosis of HIV-1 infection: a review of 32 follow-up studies.

Authors:  G S Cooper; D J Jeffers
Journal:  J Gen Intern Med       Date:  1988 Nov-Dec       Impact factor: 5.128

3.  Epidemiologic methods and methodologic vigilance.

Authors:  R I Horwitz; D F Ransohoff
Journal:  J Gen Intern Med       Date:  1988 May-Jun       Impact factor: 5.128

4.  Natural history of anal dysplasia in an HIV-infected clinical care cohort: estimates using multi-state Markov modeling.

Authors:  William C Mathews; Wollelaw Agmas; Edward R Cachay; Bard C Cosman; Christopher Jackson
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.